Previously, the Myeloproliferative Disorders Research Consortium (MPD-RC) 112 study and MPD-RC 111 study have highlighted the activity of IFNα in treatment-naïve and HU-resistant/refractory ET/PV patients, respectively [26, 30]. The gene discussed is IFNA1; the disease is acquired polycythemia vera.